Clinical Trials
All Clinical Trials - Page 31 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03928379Phase 1Completed
A Study of LY3305677 in Participants With Type 2 Diabetes
Mazdutide
- NCT04139629N/AUnknown
Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI
Gonadorelin
- NCT03870919N/AActive Not Recruiting
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
Gonadorelin
- NCT04159766Phase 2Completed
A Study With NLY01 in Subjects With Type 2 Diabetes
Exenatide
- NCT04110145Phase 2Completed
Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
Linaclotide
- NCT04086290Phase 1/Phase 2Recruiting
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Gonadorelin
- NCT04125836Phase 3Completed
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT04016974Phase 1Completed
A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
Semaglutide
- NCT04037254Phase 1/Phase 2Completed
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
Gonadorelin
- NCT04179734Phase 4Completed
Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
PT-141
- NCT04103034Phase 1Completed
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
Desmopressin
- NCT04109547Phase 3Completed
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
Semaglutide
- NCT03940235Phase 2Unknown
Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis
Gonadorelin
- NCT04113005EARLY_Phase 1Unknown
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer
Desmopressin
- NCT04026113Phase 3Completed
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
Linaclotide
- NCT04098562Phase 2Unknown
Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers
Ll-37
- NCT04097600Phase 1Completed
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
Semaglutide
- NCT04108039N/ACompleted
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
Gonadorelin
- NCT04200625N/ACompleted
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
Semaglutide
- NCT05340192Phase 1Completed
Effect of Octreotide on Saliva
Octreotide
- NCT04897958N/ACompleted
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data
Gonadorelin
- NCT04083820N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
Semaglutide
- NCT04134130N/ACompleted
The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer
Gonadorelin
- NCT03877939N/ACompleted
Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy
Kisspeptin
- NCT04050670Phase 1Completed
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
Tirzepatide
- NCT04026256Phase 4Completed
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
Teriparatide
- NCT04532801Phase 1Withdrawn
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance
Kisspeptin
- NCT05162183N/ACompleted
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Liraglutide
- NCT03648554Phase 4Unknown
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Dulaglutide
- NCT04039503Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Tirzepatide
- NCT03820830Phase 3Active Not Recruiting
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Gonadorelin
- NCT04074317Phase 2Completed
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
Pramlintide
- NCT04004988Phase 1Completed
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Tirzepatide
- NCT04076462Phase 3Completed
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT03997539Phase 2Unknown
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Gonadorelin
- NCT03841058Phase 2Active Not Recruiting
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Abaloparatide
- NCT04032197Phase 1Completed
A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
Semaglutide
- NCT04067999N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Semaglutide
- NCT04064411Phase 3Completed
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Abaloparatide
- NCT03770728Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
Efpeglenatide
- NCT04037488N/AUnknown
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Gonadorelin
- NCT03895463N/AWithdrawn
Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
Lanreotide
- NCT03987919Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Tirzepatide
- NCT03987074Phase 2Completed
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
Semaglutide
- NCT03967249Phase 2Completed
Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Octreotide
- NCT03940742Phase 1Completed
A Study of Tirzepatide in Participants With Impaired Liver Function
Tirzepatide
- NCT04029272Phase 4Unknown
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Exenatide
- NCT04028323Phase 4Unknown
Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
Octreotide
- NCT04012255Phase 1Terminated
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Semaglutide
- NCT03798912Phase 1Completed
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
Octreotide